Canada Life
ASTH icon

Canada Life’s Astrana Health ASTH Stock Holding History

Canada Life’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Sell
33,940
-1,539
-4% -$55.4K ﹤0.01% 1257
2026
Q1 		$871K Hold
35,479
– – ﹤0.01% 1389
2025
Q4 		$879K Sell
35,479
-8,376
-19% -$222K ﹤0.01% 1414
2025
Q3 		$1.27M Buy
43,855
+2,285
+5% +$61.9K ﹤0.01% 1377
2025
Q2 		$1.03M Sell
41,570
-1,877
-4% -$52.9K ﹤0.01% 1422
2025
Q1 		$1.35M Sell
43,447
-4,638
-10% -$155K ﹤0.01% 1338
2024
Q4 		$1.51M Hold
48,085
– – ﹤0.01% 1359
2024
Q3 		$2.78M Sell
48,085
-3,455
-7% -$170K ﹤0.01% 1151
2024
Q2 		$2.09M Buy
51,540
+1,517
+3% +$60.2K ﹤0.01% 1267
2024
Q1 		$2.1M Buy
50,023
+5,446
+12% +$212K ﹤0.01% 1230
2023
Q4 		$1.7M Sell
44,577
-3,213
-7% -$107K ﹤0.01% 1318
2023
Q3 		$1.47M Buy
47,790
+2,508
+6% +$86.5K ﹤0.01% 1346
2023
Q2 		$1.43M Sell
45,282
-1,374
-3% -$47.1K ﹤0.01% 1360
2023
Q1 		$1.7M Sell
46,656
-3,627
-7% -$127K ﹤0.01% 1297
2022
Q4 		$1.49M Buy
50,283
+2,877
+6% +$92.5K ﹤0.01% 1369
2022
Q3 		$1.85M Buy
47,406
+9,444
+25% +$432K 0.01% 1218
2022
Q2 		$1.46M Buy
37,962
+5,619
+17% +$214K ﹤0.01% 1305
2022
Q1 		$1.61M Buy
32,343
+214
+0.7% +$11K ﹤0.01% 1314
2021
Q4 		$2.36M Buy
32,129
+222
+0.7% +$18.2K ﹤0.01% 1113
2021
Q3 		$2.93M Buy
31,907
+20,042
+169% +$1.7M 0.01% 949
2021
Q2 		$745K Buy
11,865
+10,260
+639% +$379K ﹤0.01% 1625
2021
Q1 		$43K Hold
1,605
– – ﹤0.01% 2339
2020
Q4 		$29K Hold
1,605
– – ﹤0.01% 2468
2020
Q3 		$29K Hold
1,605
– – ﹤0.01% 2339
2020
Q2 		$26K Hold
1,605
– – ﹤0.01% 2436
2020
Q1 		$21K Hold
1,605
– – ﹤0.01% 2363
2019
Q4 		$29K Buy
+1,605
New +$26.6K ﹤0.01% 2419
2019
Q2 		– Sell
-5,121
Closed -$94K – 2802
2019
Q1 		$94K Hold
5,121
– – ﹤0.01% 2083
2018
Q4 		$99K Buy
+5,121
New +$95.8K ﹤0.01% 2155

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Canada Life's ASTH Position: Q2 2026 in Review

Canada Life reduced its Astrana Health (ASTH) stake by 4.3% in Q2 2026, selling an estimated $55.4K and leaving 33,940 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1257.

Canada Life first reported a position in ASTH in Q4 2018 and has held it in 29 quarters since. The position peaked at $2.93M in Q3 2021. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Canada Life held 33,940 shares of Astrana Health worth $1.57M as of Q2 2026.
  • Canada Life sold 1,539 Astrana Health shares in Q2 2026, an estimated $55.4K.
  • Astrana Health made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1257 holding.
  • Canada Life first reported a position in Astrana Health in Q4 2018 and has held it in 29 quarters since.
  • Canada Life's Astrana Health position peaked at $2.93M in Q3 2021.
  • 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.